Format
Sort by

Send to

Choose Destination

Search results

Items: 16

1.

Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.

Chen LT, Oh DY, Ryu MH, Yeh KH, Yeo W, Carlesi R, Cheng R, Kim J, Orlando M, Kang YK.

Cancer Res Treat. 2017 Jan 3. doi: 10.4143/crt.2016.176. [Epub ahead of print]

2.

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis.

Park JO, Ryoo BY, Yen CJ, Kudo M, Yang L, Abada PB, Cheng R, Orlando M, Zhu AX, Okusaka T.

Oncotarget. 2016 Nov 15;7(46):75482-75491. doi: 10.18632/oncotarget.12780.

3.

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.

Cuyun Carter G, Kaltenboeck A, Ivanova J, Liepa AM, San Roman A, Koh M, Rajan N, Cheng R, Birnbaum HG, Kim JS, Bang YJ.

Cancer Res Treat. 2016 Sep 12. doi: 10.4143/crt.2016.001. [Epub ahead of print]

4.

Treatment patterns in patients with advanced gastric cancer in Taiwan.

Cuyun Carter G, Kaltenboeck A, Ivanova J, Liepa AM, San Roman A, Koh M, Rajan N, Cheng R, Birnbaum H, Chen JS.

Asia Pac J Clin Oncol. 2016 Apr 25. doi: 10.1111/ajco.12497. [Epub ahead of print]

PMID:
27108762
5.

Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer.

Muro K, Oh SC, Shimada Y, Lee KW, Yen CJ, Chao Y, Cho JY, Cheng R, Carlesi R, Chandrawansa K, Orlando M, Ohtsu A.

J Gastroenterol Hepatol. 2016 Mar;31(3):581-9. doi: 10.1111/jgh.13153.

PMID:
26317322
6.

Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.

Schaefer CP, Cappelleri JC, Cheng R, Cole JC, Guenthner S, Fowler J, Johnson S, Mamolo C.

J Am Acad Dermatol. 2015 Oct;73(4):585-593.e3. doi: 10.1016/j.jaad.2015.06.049.

7.

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned.

Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M.

Cancer Res Treat. 2015 Oct;47(4):549-54. doi: 10.4143/crt.2014.362. Review.

8.

Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.

Yang JC, Ahn MJ, Nakagawa K, Tamura T, Barraclough H, Enatsu S, Cheng R, Orlando M.

Cancer Res Treat. 2015 Jul;47(3):424-35. doi: 10.4143/crt.2013.266.

9.

Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.

Cole JC, Ito D, Chen YJ, Cheng R, Bolognese J, Li-McLeod J.

Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.

12.

Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors.

Bai LJ, Liu Q, Wang M, Loo WT, Cheng RW, Chow LW, Cheung MN, Wei KY, Yip AY, Ng EL.

Int J Biol Markers. 2012 Dec 27;27(4):e322-30. doi: 10.5301/JBM.2012.9936. Erratum in: Int J Biol Markers. 2013 Apr-Jun;28(2):232.

PMID:
23250772
13.
14.

Self-construal and social comparison effects.

Cheng RW, Lam SF.

Br J Educ Psychol. 2007 Mar;77(Pt 1):197-211.

PMID:
17411495
15.

Health professionals: how do they assess new medicines?

Cheng R, Cook K, Dowman S, Lawn R, Leary J, Quinn T, Schroder K, Smith N, Tordoff J.

Pharm World Sci. 2005 Jun;27(3):236-42.

PMID:
16096894
16.

Pharmacist time requirements for counseling in an outpatient pharmacy.

Oh Y, McCombs JS, Cheng RA, Johnson KA.

Am J Health Syst Pharm. 2002 Dec 1;59(23):2346-55.

PMID:
12489376
Items per page

Supplemental Content

Loading ...
Support Center